Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Device: PaQ® Insulin Delivery DeviceDrug: Insulin, Asp(B28)-
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- CeQur Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02419859
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Terminated
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- CeQur Corporation
- Target Recruit Count
- 8
- Registration Number
- NCT02158078
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2012-02-20
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- CeQur Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT01535612
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
News
No news found